Search by Title Article Topic - Any -AdvocacyCertificationClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHFSA Annual Scientific MeetingHFSA AwardsHFSA Board Certification ReviewHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterHFSA MembershipIn The NewsIndustryJournal of Cardiac FailureMentorshipNursingPartnersPatient ResourcePodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Jul 14 2021 | Heart Failure Awareness 365: Treatment Plans, Medications, and Cardiac Rehabilitation Patient News Heart Failure Awareness 365 Patient Resource Read More Jul 10 2021 | Bayer’s KERENDIA® (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes Industry News Industry Read More Jul 9 2021 | HFSA Annual Scientific Meeting 2021 Schedule at a Glance Out Now HFSA News HFSA Annual Scientific Meeting Read More Jul 6 2021 | Breakthrough results for Jardiance® (empagliflozin) confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction Industry News Industry Read More Jun 23 2021 | New Online Community Offers HFSA Members Forum for Open Discussions and Networking HFSA News Social Media Read More Pagination First page « First Previous page ‹ Previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page Next › Last page Last »
Jul 14 2021 | Heart Failure Awareness 365: Treatment Plans, Medications, and Cardiac Rehabilitation Patient News Heart Failure Awareness 365 Patient Resource Read More
Jul 10 2021 | Bayer’s KERENDIA® (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes Industry News Industry Read More
Jul 9 2021 | HFSA Annual Scientific Meeting 2021 Schedule at a Glance Out Now HFSA News HFSA Annual Scientific Meeting Read More
Jul 6 2021 | Breakthrough results for Jardiance® (empagliflozin) confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction Industry News Industry Read More
Jun 23 2021 | New Online Community Offers HFSA Members Forum for Open Discussions and Networking HFSA News Social Media Read More
